Emergent BioSolutions Inc.
DE ˙ DB ˙ US29089Q1058
6,70 € ↓ -0,51 (-7,07%)
2026-06-03
DEL PRIS
SecurityDE:ER4 / Emergent BioSolutions Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership154,892 shares
Latest Disclosed Value $ 1,914,465
Barclays Plc reports 14.02% decrease in ownership of ER4 / Emergent BioSolutions Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 154,892 shares of Emergent BioSolutions Inc. (DE:ER4) valued at $1,589,966 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 180,150 shares of Emergent BioSolutions Inc.. This represents a change in shares of -14.02% during the quarter. The current value of the position is $1,037,776 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 154,892 -25,258 -14.02 1,914 20.53 0.0005
2026-03-31 2025-09-30 13F/A-3 EMERGENT BIOSOLUTIONS COM 29089Q105 180,150 -523 -0.29 1,589 37.85 0.0003
2026-03-19 2025-09-30 13F/A-2 EMERGENT BIOSOLUTIONS COM 29089Q105 39,308 -141,365 328 0.0001
2025-11-12 2025-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 180,150 -523 1,589 0.0003
2026-02-27 2025-06-30 13F/A-2 EMERGENT BIOSOLUTIONS COM 29089Q105 180,673 68,362 60.87 1,153 111.38 0.0003
2025-08-14 2025-06-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 180,673 68,362 1 0.0003
2025-08-13 2025-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 180,673 68,362 1 0.0001
2026-03-17 2025-03-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 112,311 17,788 18.82 546 -39.65 0.0002
2025-05-15 2025-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 112,311 17,788 1 0.0002
2026-03-19 2024-12-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 94,523 55,215 140.47 904 175.30 0.0003
2025-02-13 2024-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 94,523 55,215 1 0.0003
2026-03-31 2024-09-30 13F/A-2 EMERGENT BIOSOLUTIONS COM 29089Q105 39,308 30,792 361.58 328 465.52 0.0001
2024-11-19 2024-09-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 39,308 30,792 0 0.0001
2024-11-15 2024-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 39,308 30,792 0 0.0000
2026-03-23 2024-06-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 8,516 -29,688 -77.71 58 -39.58 0.0000
2024-08-14 2024-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 8,516 -29,688 0 0.0000
2026-03-24 2024-03-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 38,204 -101,391 -72.63 97 -71.34 0.0000
2024-05-15 2024-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 38,204 -101,391 0 0.0000
2026-03-25 2023-12-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 139,595 26,191 23.10 335 -12.99 0.0001
2024-02-15 2023-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 139,595 26,191 0 0.0001
2026-03-26 2023-09-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 113,404 -170,003 -59.99 386 -81.52 0.0002
2023-11-07 2023-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 113,404 -170,003 0 0.0002
2026-03-30 2023-06-30 13F/A-2 EMERGENT BIOSOLUTIONS COM 29089Q105 283,407 126,386 80.49 2,083 28.11 0.0013
2023-09-20 2023-06-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 283,407 126,386 2 0.0013
2023-08-03 2023-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 283,407 126,386 2 0.0013
2026-03-30 2023-03-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 157,021 -81,394 -34.14 1,627 -42.24 0.0007
2023-05-04 2023-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 157,021 -81,394 2 0.0007
2026-03-30 2022-12-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 238,415 68,225 40.09 2,816 -21.17 0.0013
2023-02-13 2022-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 238,415 68,225 3 0.0013
2022-11-03 2022-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 170,190 146,857 629.40 3,571 393.23 0.0039
2022-08-12 2022-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 23,333 -41,222 -63.86 724 -72.68 0.0004
2022-05-16 2022-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 64,555 684 1.07 2,650 -4.54 0.0021
2022-02-23 2021-12-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 63,871 17,026 36.35 2,776 18.33 0.0010
2022-02-14 2021-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 63,871 17,026 2,776 0.0003
2021-11-09 2021-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 46,845 2,817 6.40 2,346 -15.43 0.0011
2021-08-13 2021-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 44,028 -8,725 -16.54 2,774 -43.41 0.0013
2021-05-13 2021-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 52,753 11,576 28.11 4,902 32.88 0.0026
2021-02-11 2020-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 41,177 -26,485 -39.14 3,689 -47.23 0.0019
2020-11-12 2020-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 67,662 -3,857 -5.39 6,991 23.60 0.0042
2020-08-12 2020-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 71,519 -56,272 -44.03 5,656 -23.51 0.0044
2020-05-13 2020-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 127,791 -57,468 -31.02 7,394 -26.02 0.0058
2020-02-10 2019-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 185,259 128,299 225.24 9,995 235.63 0.0055
2019-11-15 2019-09-30 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 56,960 -6,338 -10.01 2,978 -2.62 0.0019
2019-11-14 2019-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 56,960 -6,338 2,978 688.5170
2019-08-14 2019-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 63,298 23,201 57.86 3,058 51.01 0.0019
2019-05-15 2019-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 40,097 13,474 50.61 2,025 28.25 0.0014
2019-02-14 2018-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 26,623 -19,959 -42.85 1,579 -48.52 0.0012
2018-11-14 2018-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 46,582 32,973 242.29 3,067 346.43 0.0021
2018-08-14 2018-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 13,609 -11,468 -45.73 687 -47.95 0.0006
2018-05-15 2018-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 25,077 2,621 11.67 1,320 26.44 0.0010
2018-02-14 2017-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 22,456 8,900 65.65 1,044 90.51 0.0009
2017-11-14 2017-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 13,556 -7,169 -34.59 548 -21.94 0.0006
2017-08-14 2017-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 20,725 19,465 1,544.84 702 1,797.30 0.0008
2017-05-15 2017-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,260 -3,676 -74.47 37 -77.16 0.0000
2017-02-14 2016-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 4,936 1,749 54.88 162 60.40 0.0002
2016-11-14 2016-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 3,187 1,140 55.69 101 74.14 0.0001
2016-08-12 2016-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 2,047 -18,751 -90.16 58 -92.26 0.0001
2016-05-16 2016-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 20,798 20,642 13,232.05 749 10,600.00 0.0011
2016-02-12 2015-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 156 -2,958 -94.99 7 -91.95 0.0000
2015-11-13 2015-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 3,114 -9,193 -74.70 87 -77.86 0.0001
2015-08-14 2015-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 12,307 11,226 1,038.48 393 1,210.00 0.0004
2015-05-19 2015-03-31 13F/A-1 EMERGENT BIOSOLUTIONS COM 29089Q105 1,081 -982 -47.60 30 -46.43 0.0000
2015-05-14 2015-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,081 30
2015-02-13 2014-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 2,063 1,035 100.68 56 166.67 0.0001
2014-11-14 2014-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 1,028 -36,568 -97.27 21 -97.46 0.0000
2014-08-14 2014-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 37,596 -41,800 -52.65 827 -58.34 0.0009
2014-05-15 2014-03-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 79,396 75,249 1,814.54 1,985 2,105.56 0.0022
2014-02-13 2013-12-31 13F EMERGENT BIOSOLUTIONS COM 29089Q105 4,147 -13,649 -76.70 90 -73.37 0.0001
2013-11-14 2013-09-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 17,796 -2,080 -10.46 338 17.77 0.0004
2013-08-14 2013-06-30 13F EMERGENT BIOSOLUTIONS COM 29089Q105 19,876 19,876 287 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.